Insider · CIK 0001849682

Dhingra Ankur

Reports to the SEC for 4 companies · SAN DIEGO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001849682

Forms 4 and 5

Insider transactions

25 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-03-05	ILMNILLUMINA, INC. · Performance SharesA Award	SVP, Chief Financial Officer	AAward	+10.9K sh	$128.24	+$1.4M	10,918
2026-03-05	ILMNILLUMINA, INC.A Award	SVP, Chief Financial Officer	AAward	+9,358 sh	$128.24	+$1.2M	34,264
2026-03-05	ILMNILLUMINA, INC. · Performance SharesA Award	SVP, Chief Financial Officer	AAward	+10.9K sh	$128.24	+$1.4M	10,918
2025-05-12	ILMNILLUMINA, INC.P Purchase	SVP, Chief Financial Officer	PPurchase	+6,100 sh	$81.21	+$495K	24,906
2025-03-05	ILMNILLUMINA, INC. · Performance SharesA Award	SVP, Chief Financial Officer	AAward	+11.4K sh	—	—	11,437
2025-03-05	ILMNILLUMINA, INC.A Award	SVP, Chief Financial Officer	AAward	+9,803 sh	—	—	18,806
2025-03-05	ILMNILLUMINA, INC. · Performance SharesA Award	SVP, Chief Financial Officer	AAward	+11.4K sh	—	—	11,437
2024-05-06	ILMNILLUMINA, INC. · Performance SharesA Award	SVP, Chief Financial Officer	AAward	+10.3K sh	—	—	10,296
2024-05-06	ILMNILLUMINA, INC. · Performance SharesA Award	SVP, Chief Financial Officer	AAward	+10.3K sh	—	—	10,296
2024-05-06	ILMNILLUMINA, INC.A Award	SVP, Chief Financial Officer	AAward	+8,826 sh	—	—	8,826
2024-03-26	SMMTSummit Therapeutics Inc.P Purchase	Chief Financial Officer	PPurchase	+100K sh	$3.75	+$375K	354,958
2023-12-13	SMMTSummit Therapeutics Inc.P Purchase	Chief Financial Officer	PPurchase	+700 sh	$2.15	+$1,505	235,258
2023-12-13	SMMTSummit Therapeutics Inc.P Purchase	Chief Financial Officer	PPurchase	+19.7K sh	$2.17	+$42.7K	254,958
2023-03-07	SMMTSummit Therapeutics Inc.P Purchase	Chief Financial Officer	PPurchase	+196K sh	$1.05	+$206K	234,558
2022-08-16	SMMTSummit Therapeutics Inc.P Purchase	Chief Financial Officer	PPurchase	+11.6K sh	$0.97	+$11.2K	38,057
2022-08-16	SMMTSummit Therapeutics Inc.P Purchase	Chief Financial Officer	PPurchase	+13K sh	$0.97	+$12.6K	39,527
2022-08-16	SMMTSummit Therapeutics Inc.P Purchase	Chief Financial Officer	PPurchase	+24.7K sh	$0.97	+$23.9K	38,196
2022-08-16	SMMTSummit Therapeutics Inc.P Purchase	Chief Financial Officer	PPurchase	+24.7K sh	$0.97	+$23.9K	38,196
2022-05-31	SMMTSummit Therapeutics Inc. · Stock Option (right to buy)A Award	Chief Financial Officer	AAward	+600K sh	—	—	600,000
2022-03-25	CDNACareDx, Inc.F Tax Payment	Chief Financial Officer	FTax Payment	−1,254 sh	$37.90	−$47.5K	33,146
2022-02-02	CDNACareDx, Inc.A Award	Chief Financial Officer	AAward	+19.9K sh	—	—	34,400
2022-02-02	CDNACareDx, Inc. · Employee Stock Option (right to buy)A Award	Chief Financial Officer	AAward	+34.9K sh	—	—	34,900
2021-11-24	CDNACareDx, Inc.P Purchase	Chief Financial Officer	PPurchase	+5,000 sh	$42.34	+$212K	5,000
2021-03-25	CDNACareDx, Inc. · Employee Stock Option (right to buy)A Award	Chief Financial Officer	AAward	+30K sh	—	—	30,000
2021-03-25	CDNACareDx, Inc.A Award	Chief Financial Officer	AAward	+14.5K sh	—	—	14,500

Recent filings

Accepted (ET)
Mar 94
Dhingra Ankur0001110803-26-000072
SEC(opens sec.gov)
May 144
Dhingra Ankur0001127602-25-014280
SEC(opens sec.gov)
Mar 74
Dhingra Ankur0001127602-25-008707
SEC(opens sec.gov)
May 84
Dhingra Ankur0001127602-24-014675
SEC(opens sec.gov)
Mar 274
Dhingra Ankur0001599298-24-000046
SEC(opens sec.gov)
Dec 134
Dhingra Ankur0001599298-23-000101
SEC(opens sec.gov)
Mar 84/A
Dhingra Ankur0001849682-23-000002
SEC(opens sec.gov)
Mar 84
Dhingra Ankur0001849682-23-000004
SEC(opens sec.gov)
Aug 174
Dhingra Ankur0001599298-22-000102
SEC(opens sec.gov)
Jun 24
Dhingra Ankur0001849682-22-000003
SEC(opens sec.gov)
Mar 284
Dhingra Ankur0001217234-22-000070
SEC(opens sec.gov)

Companies

Address

5200 ILLUMINA WAY

SAN DIEGO, CA, 92122